
Post
Yuvi.
$LLY,昨日retatrutide头对头数据是否足以改变竞争格局?公司称试验中其减重效果超过Ozempic最高获批剂量两倍,且今天有Q3业绩电话会。临床结果可增强管线预期,但安全性、完整终点和产能仍决定商业转化。若详细数据稳健、供给扩张兑现,判断更积极;若耐受性或生产限制显现,我会下调峰值预期。
Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more
Replies
No comments yet. Be the first to reply!
Today’s market buzz
1#Anthropic launches IPO roadshow, valuation rebounds to $1.8 trillion
Hot
2#Twenty One Capital increased its holdings by 154 BTC, marking the first time since July 2025
3#Gold fell below $3745, wiping out nearly $800 billion in market value